Topic
cancer-immunotherapy research, explained
1 open-access cancer-immunotherapy studies, each with a flashcard deck and a quiz.
- How does cisplatin boost checkpoint therapy?
Cisplatin-triggered tumor ferroptosis polarized N1 neutrophils and remodeled cold NSCLC tumors toward hotter T-cell/Th1 states, synergizing with ferroptosis activators in EGFR-mutant settings.